Valneva CMO Juan Carlos Jaramillo
Covid-19 roundup: Valneva defends vaccine in wake of unflattering booster study; Merck goes after Pfizer’s new antiviral — report
Falling way behind the frontrunners in delivering a Covid-19 vaccine, French biotech Valneva has placed high hopes on boosters.
Which may be why it is …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
